Pfizer: covid-19 antiviral pill cut rates of hospitalisation, death risk by 89%, says DR. Mikael Dolsten

Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced it will soon ask the U.S. FDA and international regulators to authorize it.

via Economictimes